screening for skin cancer
Jump to navigation
Jump to search
Indications
- insufficient evidence to recommend screening for skin cancer in asymptomatic adults without history of premalignant or malignant skin lesions (USPSTF)[3][5]
- risk factors that warrant screening
- multiple dysplastic nevi
- basal cell nevus syndrome
- history of melanoma or family history of melanoma
- history of non-melanoma skin cancer or family history of non-melanoma skin cancer
- immunosuppression
- history of phototherapy
- history of multiple blistering sunburns
- red or ligh colored hair; light colored eyes
Complications
- primary care-based melanoma screening associated with increased detection of thin melanoma, raising concern of among dermatologists of overdiagnosis[6]
Management
- any new or changing nevus should be evaluated for possible biopsy[1]
- see skin cancer for prevention
More general terms
Additional terms
References
- ↑ 1.0 1.1 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16, 17. American College of Physicians, Philadelphia 1998, 2009, 2012, 2015
- ↑ US Preventive Services Task Force. Screening for skin cancer: recommendations and rationale. Am J Prev Med. 2001 Apr;20(3 Suppl):44-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11306231
- ↑ 3.0 3.1 US Preventive Services Task Force. Dec 2015 Draft Evidence Review for Skin Cancer: Screening Draft Recommendation Statement. Skin Cancer: Screening http://www.uspreventiveservicestaskforce.org/Page/Name/us-preventive-services-task-force-opportunities-for-public-comment
- ↑ Choudhury K, Volkmer B, Greinert R et al Effectiveness of skin cancer screening programmes. Br J Dermatol. 2012 Aug;167 Suppl 2:94-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22881593
- ↑ 5.0 5.1 US Preventive Services Task Force Screening for Skin Cancer. US Preventive Services Task Force Recommendation Statement JAMA. 2016;316(4):429-435 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27458948 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=2536643
Wernli KJ,Henrikson NB, Morrison CC et al Screening for Skin Cancer in Adults. Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;316(4):436-447 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27458949 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=2536642
Nahar VK, Mayer JE, Grant-Kels JM The Case for Skin Cancer Screening With Total-Body Skin Examinations. JAMA Oncol. Published online July 26, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27459540 <Internet> http://oncology.jamanetwork.com/article.aspx?articleid=2537114
Swetter SM, Geller AC, Halpern AC What the USPSTF "Insufficient" Skin Cancer Screening Recommendation Means for Primary Care Clinicians and Dermatologists. JAMA Dermatol. Published online July 26, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27459324 <Internet> http://archderm.jamanetwork.com/article.aspx?articleid=2536823
Linos E, Katz KA, Colditz GA Skin Cancer - The Importance of Prevention JAMA Intern Med. Published online July 26, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27459394 <Internet> http://archinte.jamanetwork.com/article.aspx?articleid=2537026
US Preventive Services Task Force Screening for Skin CancerUS Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(15):1290-1295 PMID: https://www.ncbi.nlm.nih.gov/pubmed/37071089 https://jamanetwork.com/journals/jama/fullarticle/2803797
Henrikson NB, Ivlev I, Blasi PR et al Skin Cancer Screening. Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2023;329(15):1296-1307. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37071090 https://jamanetwork.com/journals/jama/fullarticle/2803798 - ↑ 6.0 6.1 Matsumoto M, Wack S, Weinstock MA et al Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System. JAMA Dermatol. Published online April 6, 2022. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35385051 https://jamanetwork.com/journals/jamadermatology/fullarticle/2790694